- • Up to 20% off your first purchase
- • Bulk quantities available
- • Citation Reward application
Sample Application
- Animal health test
- In-vitro diagnostics
- Food & Feed Safety
- Environmental Safety
- New drug discovery
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
Anti-BMR1A/ BMPR1A/ 10q23del monoclonal antibody
Anti-BMR1A/ BMPR1A/ 10q23del antibody for FACS & in-vivo assay
Go to BMPR1A/BMPR1A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
MSDSProduct information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-MP0136-Ab-1/ GM-Tg-hg-MP0136-Ab-2 | Anti-Human BMPR1A monoclonal antibody | Human |
| GM-Tg-rg-MP0136-Ab-1/ GM-Tg-rg-MP0136-Ab-2 | Anti-Rat BMPR1A monoclonal antibody | Rat |
| GM-Tg-mg-MP0136-Ab-1/ GM-Tg-mg-MP0136-Ab-2 | Anti-Mouse BMPR1A monoclonal antibody | Mouse |
| GM-Tg-cynog-MP0136-Ab-1/ GM-Tg-cynog-MP0136-Ab-2 | Anti-Cynomolgus/ Rhesus macaque BMPR1A monoclonal antibody | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-MP0136-Ab-1/ GM-Tg-felg-MP0136-Ab-2 | Anti-Feline BMPR1A monoclonal antibody | Feline |
| GM-Tg-cang-MP0136-Ab-1/ GM-Tg-cang-MP0136-Ab-2 | Anti-Canine BMPR1A monoclonal antibody | Canine |
| GM-Tg-bovg-MP0136-Ab-1/ GM-Tg-bovg-MP0136-Ab-2 | Anti-Bovine BMPR1A monoclonal antibody | Bovine |
| GM-Tg-equg-MP0136-Ab-1/ GM-Tg-equg-MP0136-Ab-2 | Anti-Equine BMPR1A monoclonal antibody | Equine |
Size： 1mg | 10mg | 100mg
Product Description
| Catalog No. | GM-Tg-hg-MP0136-Ab-1/ GM-Tg-hg-MP0136-Ab-2; GM-Tg-rg-MP0136-Ab-1/ GM-Tg-rg-MP0136-Ab-2; GM-Tg-mg-MP0136-Ab-1/ GM-Tg-mg-MP0136-Ab-2; GM-Tg-cynog-MP0136-Ab-1/ GM-Tg-cynog-MP0136-Ab-2; GM-Tg-felg-MP0136-Ab-1/ GM-Tg-felg-MP0136-Ab-2; GM-Tg-cang-MP0136-Ab-1/ GM-Tg-cang-MP0136-Ab-2; GM-Tg-bovg-MP0136-Ab-1/ GM-Tg-bovg-MP0136-Ab-2; GM-Tg-equg-MP0136-Ab-1/ GM-Tg-equg-MP0136-Ab-2 |
| Products Name | Anti-BMPR1A monoclonal antibody |
| Format | mab |
| Target Name | BMPR1A |
| Protein Sub-location | Transmembrane Protein |
| Category of antibody | FACS/Biofunctional Antibody, Cytokine antibody |
| Derivation (species) | Mouse |
| CH1+2+3 Isotype (Receptor identification) | IgG |
| Type of Light Chain (VD-LC) | N/A |
| Expression platform | Mammalian Expression |
| Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
| Tag | Fc |
| Products description | Pre-made anti-BMPR1A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
| Target Antigen | Products Developing | Multi-species BMR1A/ BMPR1A/ 10q23del VLP (virus-like particle) (Products Developing) |
| Cytokine | GM-Tg-g-MP0136-Ag-1 | bone morphogenetic protein receptor, type IA (BMPR1A) protein |
| ORF Viral Vector | pGMLPm003040 | mouse Bmpr1a Lentivirus plasmid |
| ORF Viral Vector | vGMLPm003040 | mouse Bmpr1a Lentivirus particle |
Target information
| Target ID | GM-MP0136 |
| Target Name | BMPR1A |
| Gene ID | 657,12166,81507,696898,489077,101089548,404101,100064367 |
| Gene Symbol and Synonyms | 10q23del,1110037I22Rik,ACVRLK3,ALK-3,ALK3,Bmpr,BMPR-1A,BMPR-IA,BMPR1A,CD292,SKR5 |
| Uniprot Accession | P36894,Q78EA7 |
| Uniprot Entry Name | BMR1A_HUMAN,BMR1A_RAT |
| Protein Sub-location | Transmembrane Protein |
| Category | Cytokine Target |
| Disease | Cancer |
| Gene Ensembl | ENSG00000107779 |
| Target Classification | Kinase, Tumor-associated antigen (TAA) |
The target: BMPR1A, gene name: BMPR1A, also named as 10q23del, ACVRLK3, ALK3, CD292, SKR5. The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.
Facebook
LinkedIn
Twitter
